SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2025 and 2024:

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2025
Revenue	$	2,829,270		$	172		$	-		$	1,641,433		$	4,470,875
Cost of Sales		(2,580,462	)		(247	)		-			(641,206	)		(3,221,915	)
Gross Margin		248,808			(75	)		-			1,000,227			1,248,960
Operating Expenses		(3,467,772	)		(590,995	)		(1,366,561	)		(10,974,215	)		(16,399,543	)
Operating Income (Loss)		(3,218,964	)		(591,070	)		(1,366,561	)		(9,973,988	)		(15,150,583	)
Other Income (Expense)		(1,754,852	)		(2,050,303	)		(669,113	)		(29,293,629	)		(33,767,897	)
Net Income (Loss) Before Income Tax	$	(4,973,816	)	$	(2,641,373	)	$	(2,035,674	)	$	(39,267,617	)	$	(48,918,480	)

	Real Estate			Digital Transformation Technology			Biohealth Business			Other			Total
Year Ended on December 31, 2024
Revenue	$	19,608,184		$	-		$	-		$	1,507,715		$	21,115,899
Cost of Sales		(12,034,348	)		-			(3,370	)		(744,906	)		(12,782,624	)
Gross Margin		7,573,836			-			(3,370	)		762,809			8,333,275
Operating Expenses		(1,793,188	)		(616,403	)		(1,076,095	)		(8,964,666	)		(12,450,351	)
Operating Income (Loss)		5,780,648			(616,403	)		(1,079,465	)		(8,201,857	)		(4,117,076	)
Other Income (Expense)		1,522			(2,947,968	)		(139,737	)		3,188,229			102,046
Net Income (Loss) Before Income Tax	$	5,782,170		$	(3,564,371	)	$	(1,219,202	)	$	(5,013,628	)	$	(4,015,030	)